C12N 2502/256
Renal cells
C12N2502/256 (Renal cells) appears on 29 US grants and 44 published applications in this corpus.
Search patents in C12N- Granted patents
- 29
- Published applications
- 44
- Assignees
- 33
- Inventors
- 93
- Latest grant
- 21 Oct 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1996 | 1 | 0 |
| 1997 | 1 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 1 | 0 |
| 2001 | 3 | 4 |
| 2002 | 3 | 1 |
| 2003 | 1 | 3 |
| 2004 | 0 | 3 |
| 2005 | 3 | 1 |
| 2006 | 1 | 0 |
| 2007 | 0 | 1 |
| 2008 | 0 | 1 |
| 2009 | 0 | 0 |
| 2010 | 1 | 1 |
| 2011 | 0 | 1 |
| 2012 | 1 | 2 |
| 2013 | 2 | 0 |
| 2014 | 0 | 1 |
| 2015 | 0 | 1 |
| 2016 | 1 | 4 |
| 2017 | 2 | 1 |
| 2018 | 1 | 1 |
| 2019 | 1 | 3 |
| 2020 | 0 | 2 |
| 2021 | 1 | 2 |
| 2022 | 0 | 1 |
| 2023 | 3 | 1 |
| 2024 | 1 | 3 |
| 2025 | 1 | 3 |
| 2026 | 0 | 3 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Compositions comprising cell-delivered vesicles and uses thereof21 Oct 2025US 12,447,179 B2ProKidney
- Engineered renal tissues, arrays thereof, and methods of making the same9 Jan 2024US 11,867,689 B2Organovo, Inc.
- Production method for kidney-like tissue27 Jun 2023US 11,685,902 B2Tokushima University
- Method for the formation of renal tubules7 Mar 2023US 11,597,909 B2Leibniz-Institut FüR Polymer-Forschung Dresden E.V.
- Therapeutic methods using erythrocytes31 Jan 2023US 11,564,948 B2Sangui Bio Pty Ltd
- Method for culturing muscle-derived cells, and culturing device containing muscle-derived cells6 Aug 2026US 2026/0226415 A1IntegriCulture Inc.
- Method of determining fusogenic potential of sperm and use thereof in assisted fertilization and drug screening14 May 2026US 2026/0133182 A1Technion Research & Development Foundation Limited
- Compositions comprising cell-delivered vesicles and uses thereof26 Feb 2026US 2026/0053858 A1ProKidney
- Method for culturing liver-derived cells and culture system including liver-derived cells18 Dec 2025US 2025/0382579 A1IntegriCulture Inc.
- Selective cell therapy for the treatment of renal failure15 May 2025US 2025/0154471 A1Wake Forest University Health Sciences
Most cited
By later US patents
- Method and compositions of a bioartificial kidney suitable for use in vivo or ex vivo99US 5,686,289 AUniversity of Michigan · 1997
- Methods and compositions of a bioartificial kidney suitable for use in vivo or ex vivo87US 5,549,674 AThe Regents of the University of Michigan · 1996
- Methods and compositions of a bioartificial kidney suitable for use in vivo or ex vivo50US 6,150,164 AThe Regents of the University of Michigan · 2000
- Mixed cell diagnostic systems43US 6,168,915 ADiagnostic Hybrids, Inc. · 2001
- Mixed cell diagnostic systems30US 6,376,172 B1Diagnostic Hybrids, Inc. · 2002